New Key Statistics Module, Z-Score and F-Score
NAS:DNLI Key Ratios
Market Cap $ M | 3,546.20 |
Enterprise Value $ M | 2,698.91 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.56 |
Price/Sales | 2,752.22 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -2.85 |
Beneish M-Score | -38.17 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.45 |
EV-to-EBITDA | -5.55 |
PEG | -- |
Shares Outstanding M | 143.17 |
Net Margin (%) | -33,121.86 |
Operating Margin % | -39,085.40 |
Pre-tax Margin (%) | -33,119.50 |
Quick Ratio | 12.46 |
Current Ratio | 12.46 |
ROA % (ttm) | -30.95 |
ROE % (ttm) | -33.96 |
ROIC % (ttm) | -157.45 |
Dividend Yield % | -- |
Altman Z-Score | 16.95 |
DNLI Number of Guru Trades
DNLI Volume of Guru Trades
Gurus Latest Trades with NAS:DNLI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:DNLI is held by these investors
Total 2
Denali Therapeutics Inc Insider Transactions
No Available Data
News about NAS:DNLI
Total 0- 1